Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Net
Ratios

Benitec Biopharma (BNTC) Accumulated Depreciation & Amortization (2019 - 2025)

Benitec Biopharma's Accumulated Depreciation & Amortization history spans 7 years, with the latest figure at $52000.0 for Q1 2025.

  • For Q1 2025, Accumulated Depreciation & Amortization fell 14.75% year-over-year to $52000.0; the TTM value through Mar 2025 reached $52000.0, down 14.75%, while the annual FY2024 figure was $87000.0, 36.03% down from the prior year.
  • Accumulated Depreciation & Amortization for Q1 2025 was $52000.0 at Benitec Biopharma, up from $39000.0 in the prior quarter.
  • Across five years, Accumulated Depreciation & Amortization topped out at $231000.0 in Q2 2021 and bottomed at $17000.0 in Q4 2023.
  • The 5-year median for Accumulated Depreciation & Amortization is $52000.0 (2021), against an average of $82117.6.
  • The largest annual shift saw Accumulated Depreciation & Amortization crashed 80.12% in 2023 before it surged 129.41% in 2024.
  • A 5-year view of Accumulated Depreciation & Amortization shows it stood at $55000.0 in 2021, then dropped by 25.45% to $41000.0 in 2022, then plummeted by 58.54% to $17000.0 in 2023, then soared by 129.41% to $39000.0 in 2024, then soared by 33.33% to $52000.0 in 2025.
  • Per Business Quant, the three most recent readings for BNTC's Accumulated Depreciation & Amortization are $52000.0 (Q1 2025), $39000.0 (Q4 2024), and $25000.0 (Q3 2024).